Omabit Announces Seed Financing to Advance Drug-Development Decision-Making
Omabit announced seed financing backed by Bright Ventures.
Related stories
Linde Reports Q3 Revenue of $9.40 Billion, Adjusted EPS of $4.59
Linde reported Q3 2026 revenue of $9.40 billion and adjusted EPS of $4.59, above FactSet estimates of $9.16 billion and $4.52. It projected full-year adjusted EPS of $17.82-$17.92
M impact | EQUITY | Oct 29, 2026, 11:15 AM UTC
Bristol Myers Squibb Reports Q3 Opdivo Revenue of $2.37 Billion
M impact | EQUITY | Oct 29, 2026, 11:03 AM UTC
Quanta Services cites broad-based electric infrastructure demand for Q3 revenue growth
M impact | EQUITY | Oct 29, 2026, 11:02 AM UTC
Garrett Motion Approves $250 Million Share Repurchase Program for 2027
M impact | EQUITY | Oct 29, 2026, 11:02 AM UTC
Global Payments Q3 Results Due November 5; Revenue Estimate 3.18B USD
Global Payments is scheduled to report before market open on November 5. Revenue is estimated at 3.18 billion USD and EPS at 3.58 USD.
M impact | EQUITY | Oct 29, 2026, 11:02 AM UTC
Evergy Q3 Results Due November 05; Revenue Estimate 1.93B USD
Evergy is scheduled to report before the market opens on November 05. Revenue is estimated at 1.93 billion USD and EPS at 2.33 USD.
M impact | EQUITY | Oct 29, 2026, 11:02 AM UTC